Rocket Pharmaceuticals, Inc. (RCKT) Capital expenditures 2016–2025
Rocket Pharmaceuticals, Inc. (RCKT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$440,000FY2025 · since FY2016: $335,000 → $440,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $440,000 | -92.5% |
| FY2024 | $5.9M | -64.3% |
| FY2023 | $16.4M | +96.6% |
| FY2022 | $8.4M | +9.7% |
| FY2021 | $7.6M | -63.0% |
| FY2020 | $20.6M | -11.4% |
| FY2019 | $23.3M | +1501.4% |
| FY2018 | $1.5M | +91.2% |
| FY2017 | $760,000 | +126.9% |
| FY2016 | $335,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice